Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Outstanding (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Shares Outstanding data on record, last reported at $10.2 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 553.28% year-over-year to $10.2 million; the TTM value through Sep 2025 reached $10.2 million, up 553.28%, while the annual FY2024 figure was $4.4 million, 92.52% down from the prior year.
  • Shares Outstanding reached $10.2 million in Q3 2025 per TNXP's latest filing, up from $7.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $155.6 million in Q3 2024 and bottomed at $20926.0 in Q4 2023.
  • Average Shares Outstanding over 3 years is $27.9 million, with a median of $10.2 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding: crashed 95.48% in 2024, then surged 26716.19% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $20926.0 in 2023, then surged by 20859.23% to $4.4 million in 2024, then soared by 131.84% to $10.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $10.2 million in Q3 2025, $7.5 million in Q2 2025, and $6.9 million in Q1 2025.